Granulocyte macrophage-colony stimulating factor (GM-CSF) induced severe atypical rash in a patient of non-hodgkin's lymphoma
Gautam Kumar Singh, Anuj Bhatnagar, Debdeep Mitra and 3 more
Indian Journal of Dermatology · 2022
doi:10.4103/ijd.ijd_66_21 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Granulocyte-macrophage colony-stimulating factor (GM-CSF) infusion has been reported with the development of transient maculopapular rash with spontaneous resolution. A 54-year-old Indian female developed intense erythematous generalised rash involving the face, trunk, extremities, palms and soles following GM-CSF infusion. Focal exudation and purpura were seen. Infusion was stopped and she was managed with a short course of systemic steroids. As yet, the development of such an atypical, severe rash following this cytokine infusion has not been reported in the literature.
Abstract licence: CC BY-NC-SA
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.